SILVIYA DRAGIEVA: Open Payments
NPI 1205350113 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 13 payments from 6 companies in 2025. Trend: 2023 $883 · 2024 $1,143 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $282 |
| ABBVIE INC. | 4 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $14 |
Products named: FARXIGA, BREZTRI, QULIPTA, LINZESS, AIRSUPRA, Kerendia, NEXLETOL, OTEZLA.
Industry payments across FL — which companies pay providers there.
